Peginterferon alfa-2b for mycosis fungoides.
Yanagi
Teruki
T
Shimizu
Tadamichi
T
Ujiie
Hideyuki
H
Ito
Miki
M
Abe
Riichiro
R
Tsuji-Abe
Yukiko
Y
Hige
Shuhei
S
Shimizu
Hiroshi
H
D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001132:Arm; D003937:Diagnosis, Differential; D004337:Drug Carriers / Q000008:administration & dosage / Q000627:therapeutic use; D019698:Hepatitis C, Chronic; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D007866:Leg; D008297:Male; D009182:Mycosis Fungoides / Q000188:drug therapy* / Q000473:pathology; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000998:Antiviral Agents; D004337:Drug Carriers; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b